Laura Seestaller‐Wehr

Author

Also Known As

L. Seestaller-Wehr, Laura M Seestaller-Wehr, Laura M. Seestaller-Wehr, Laura M. Seestaller‐Wehr, Laura Seestaller-Wehr, Laura Seestaller‐Wehr

127

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

GlaxoSmithKline (United States)Women's Health Research Institute GlaxoSmithKline (United Kingdom)Target (United States)CRUK Lung Cancer Centre of Excellence

About

Laura Seestaller‐Wehr is an author at GlaxoSmithKline (United States) specializing in medicine, cell biology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	836
2	Cell Biology	6	6	774
3	Health Sciences	1	1	76
4	Natural Sciences	1	1	50
5	Biochemistry	1	1	50

Laura Seestaller‐Wehr

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
The BRAF and MEK Inhibitors Dabrafenib and Trametinib: Effects on Immune Function and in Combination with Immunomodulatory Antibodies Targeting PD-1, PD-L1, and CTLA-4 Li Liu, Patrick A. Mayes, Stephen D. Eastman, Clinical Cancer Research	2015	440
Tumor-immune profiling of murine syngeneic tumor models as a framework to guide mechanistic studies and predict therapy response in distinct tumor microenvironments Jong W. Yu, Sabyasachi Bhattacharya, Niranjan Yanamandra, PLoS ONE Unique Tumor-immune InfiltrateNovel Anti-cancer ImmunotherapiesImmunologyBiological MicroenvironmentsImmunoediting	2018	197
Evaluation of B cell maturation antigen as a target for antibody drug conjugate mediated cytotoxicity in multiple myeloma Lydia Lee, Danton Bounds, Jennifer C. Paterson, British Journal of Haematology ImmunologyPathologyImmunotherapyTumor BiologyMyeloid Neoplasia	2016	196
The Orphan Receptor Tyrosine Kinase Ror2 Modulates Canonical Wnt Signaling in Osteoblastic Cells Julia Billiard, Deana S. Way, Laura Seestaller‐Wehr, Molecular Endocrinology MechanobiologySclerostinDevelopmental BiologySignal TransductionBone Morphogenic Protein	2004	164
A small molecule inhibitor of the Wnt antagonist secreted frizzled-related protein-1 stimulates bone formation Peter V.N. Bodine, Barbara Stauffer, Helga Ponce‐de‐Leon, Bone SclerostinSignal TransductionBone Morphogenic ProteinWnt AntagonistMedicine	2009	124
Belantamab Mafodotin (GSK2857916) Drives Immunogenic Cell Death and Immune-mediated Antitumor Responses<i>In Vivo</i> Rocío Montes de, Alireza Alavi, Nick Vitali, Molecular Cancer Therapeutics	2021	99
The Orphan Receptor Tyrosine Kinase Ror2 Promotes Osteoblast Differentiation and Enhances ex Vivo Bone Formation Yan Liu, Ramesh A. Bhat, Laura Seestaller‐Wehr, Molecular Endocrinology Vivo Bone FormationSclerostinBone RepairMatrix MineralizationOsteoporosis	2006	76
Bone anabolic effects of parathyroid hormone are blunted by deletion of the Wnt antagonist secreted frizzled‐related protein‐1 Peter V.N. Bodine, Laura Seestaller‐Wehr, Yogendra P. Kharode, Journal of Cellular Physiology	2006	65
Identification of Diarylsulfone Sulfonamides as Secreted Frizzled Related Protein-1 (sFRP-1) Inhibitors Ariamala Gopalsamy, Mengxiao Shi, Barbara Stauffer, Journal of Medicinal Chemistry Medicinal ChemistryDrug TargetDiarylsulfone SulfonamidesSfrp-1 InhibitorsBiochemistry	2008	50
PF558 THE ANTI-BCMA ANTIBODY-DRUG CONJUGATE GSK2857916 DRIVES IMMUNOGENIC CELL DEATH AND IMMUNE-MEDIATED ANTI-TUMOR RESPONSES, AND IN COMBINATION WITH AN OX40 AGONIST POTENTIATES IN VIVO ACTIVITY Rocío Montes de, Sabyasachi Bhattacharya, Nick Vitali, HemaSphere ApoptosisImmunologyImmunoeditingCell DeathImmunotherapeutics	2019	17

Page 1